References for The Dementias: Hope Through Research

Ambegaonkar, A., Ritchie, C., & de la Fuente Garcia, S. (2021). The Use of Mobile Applications as Communication Aids for People with Dementia: Opportunities and Limitations. Journal of Alzheimer’s Disease Reports, 5(1), 681–692.
Astell, A. J., Bouranis, N., Hoey, J., Lindauer, A., Mihailidis, A., Nugent, C., Robillard, J. M., & Technology and Dementia Professional Interest Area … (2019). Technology and Dementia: The Future is Now. Dementia and Geriatric Cognitive Disorders, 47(3), 131–139.
Basting, A. (2018). Building creative communities of care: Arts, dementia, and hope in the United States. Dementia, 17(6), 744–754.
Chen, Y., Liu, Q., Liu, J., Wei, P., Li, B., Wang, N., Liu, Z., & Wang, Z. (2022). Revealing the Modular Similarities and Differences Among Alzheimer’s Disease, Vascular Dementia, and Parkinson’s Disease in Genomic Networks. NeuroMolecular Medicine, 24(2), 125–138.
Elahi, F. M., & Miller, B. L. (2017). A clinicopathological approach to the diagnosis of dementia. Nature Reviews Neurology, 13(8), 457–476.
García-Morales, V., González-Acedo, A., Melguizo-Rodríguez, L., Pardo-Moreno, T., Costela-Ruiz, V. J., Montiel-Troya, M., & Ramos-Rodríguez, J. J. (2021). Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer’s Disease. Biomedicines, 9(12), 1910.
Greaves, C. V., & Rohrer, J. D. (2019). An update on genetic frontotemporal dementia. Journal of Neurology, 266(8), 2075–2086.
Montero-Odasso, M., Ismail, Z., & Livingston, G. (2020). One third of dementia cases can be prevented within the next 25 years by tackling risk factors. The case “for” and “against.” Alzheimer’s Research & Therapy, 12(1), 81.
Pardo-Moreno, T., González-Acedo, A., Rivas-Domínguez, A., García-Morales, V., García-Cozar, F. J., Ramos-Rodríguez, J. J., & Melguizo-Rodríguez, L. (2022). Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives. Pharmaceutics, 14(6), 1117.
Peters, R., Booth, A., Rockwood, K., Peters, J., D’Este, C., & Anstey, K. J. (2019). Combining modifiable risk factors and risk of dementia: A systematic review and meta-analysis. BMJ Open, 9(1), e022846.
Ribarič, S. (2022). Physical Exercise, a Potential Non-Pharmacological Intervention for Attenuating Neuroinflammation and Cognitive Decline in Alzheimer’s Disease Patients. International Journal of Molecular Sciences, 23(6), 3245.
Starchina, Yu. A., & Zakharov, V. V. (2021). Severity and treatment of cognitive impairment. Neurology, Neuropsychiatry, Psychosomatics, 13(3), 119–124.
Testad, I., Kajander, M., Gjestsen, M. T., & Dalen, I. (2020). Health promotion intervention for people with early‐stage dementia: A quasi‐experimental study. Brain and Behavior, 10(12).
Tisher, A., & Salardini, A. (2019). A Comprehensive Update on Treatment of Dementia. Seminars in Neurology, 39(02), 167–178.
Vale, F. A. C., Tayra, J. T., & Tellaroli Spedo, C. (2022). Principles of Pharmacology in Dementia. In G. A. A. dos Santos (Ed.), Pharmacological Treatment of Alzheimer’s Disease (pp. 15–29). Springer International Publishing.
Wolff, J. L., Benge, J. F., Cassel, C. K., Monin, J. K., & Reuben, D. B. (2021). Emerging topics in dementia care and services. Journal of the American Geriatrics Society, 69(7), 1763–1773.
Yu, D., Li, X., & Lai, F. H. (2022). The effect of virtual reality on executive function in older adults with mild cognitive impairment: A systematic review and meta-analysis. Aging & Mental Health, 1–11.
Zhang, Y.-R., Wang, J.-J., Chen, S.-F., Wang, H.-F., Li, Y.-Z., Ou, Y.-N., Huang, S.-Y., Chen, S.-D., Cheng, W., Feng, J.-F., Dong, Q., & Yu, J.-T. (2022). Peripheral immunity is associated with the risk of incident dementia. Molecular Psychiatry, 27(4), 1956–1962.
Zucchella, C., Sinforiani, E., Tamburin, S., Federico, A., Mantovani, E., Bernini, S., Casale, R., & Bartolo, M. (2018). The Multidisciplinary Approach to Alzheimer’s Disease and Dementia. A Narrative Review of Non-Pharmacological Treatment. Frontiers in Neurology, 9, 1058.